STOCK TITAN

Aeluma (ALMU) SEC Filings, Jul-Sep 2026

ALMU NASDAQ

Aeluma, Inc. filings document the reporting record of a Nasdaq-listed emerging growth semiconductor company developing scalable photonic and electronic technologies. Its periodic and current reports cover financial results, quarterly reporting, Regulation FD materials, investor presentations and public-company disclosure controls.

The company’s SEC filings also describe capital-structure activity involving common stock, shelf registration, underwriting agreements and sales-agreement arrangements for registered equity issuance. Governance disclosures include annual meeting voting results, director elections and shareholder approvals, while other current reports address material definitive agreements and Rule 10b5-1 trading-plan disclosures.

Rhea-AI Summary

Aeluma, Inc. CEO and director Jonathan Klamkin reported the sale of 100,000 shares held through a Family Trust on September 21, 2026, at a weighted average $13.3532 per share; the sale was under a Rule 10b5-1 plan adopted May 23, 2026. The trust held 1,226,995 shares after the sale. Klamkin also received 31,771 RSUs, 12,675 shares as a stock award in lieu of a cash bonus, and 75,135 options with a $13.61 exercise price. Separately, 4,547 shares were delivered or withheld for payment of exercise price or tax liability at $13.61 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. director Byron Michael exercised 25,000 fully vested stock options on September 21, 2026, at an exercise price of $5.93 per share, acquiring 25,000 common shares. After the transaction, his reported holdings were 38,343 common shares and 20,833 stock options. No Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) is the issuer of common stock for which the Klamkin Drelle Gelasca Family Trust dated 08/28/2025 has filed a notice to sell shares under Rule 144. The trust plans to sell 100,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.

The planned sale has an aggregate market value of $1,272,500, with 19,265,671 shares of Aeluma common stock stated as outstanding as of the notice, and the securities were originally acquired as Founders Shares on October 27, 2020. In the prior three months, related 10b5-1 sales by Jonathan Klamkin totaled 40,000 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.13%
Tags
other
Rhea-AI Summary

Aeluma, Inc. (ALMU) reported full-year results for the year ended June 30, 2026, highlighting its transition from primarily R&D activities toward early commercialization of photonic and electronic technologies for AI datacom, mobile, defense, aerospace, and quantum applications. Revenue was $4.46 million, primarily from U.S. government development contracts, and the company remains far from scale production, with commercial orders still small and in qualification.

The net loss widened to $9.16 million as operating expenses more than doubled, driven by higher R&D and general and administrative spending to expand engineering, manufacturing readiness, and go-to-market capabilities. Aeluma strengthened its balance sheet through equity offerings and an at-the-market program, ending the year with $56.01 million in cash and cash equivalents and $60.66 million in total assets, with no debt reported and stockholders’ equity of $56.93 million.

The company describes a capital‑efficient manufacturing model that combines internal epitaxy and prototyping with external foundries such as Tower Semiconductor and Sumitomo Chemical Advanced Technologies. Aeluma also discloses a letter of intent with the U.S. Department of Commerce for potential CHIPS and Science Act funding, which remains subject to definitive agreements, milestones, and possible business restrictions. Management reports a material weakness in internal control over financial reporting related to limited technical accounting resources, and is implementing remediation efforts, including hiring a CFO and engaging a specialist firm.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.04%
Tags
annual report
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) reported fourth-quarter and full fiscal year 2026 results for the year ended June 30, 2026. Revenue was $4.46 million, slightly below $4.67 million a year earlier, while the GAAP net loss widened to $9.16 million from $3.02 million, reflecting significantly higher R&D and general and administrative spending.

Adjusted EBITDA declined to -$5.22 million from $0.19 million. Liquidity strengthened, with cash and cash equivalents at $56.01 million, driven mainly by a $43.48 million public offering and warrant exercises, lifting stockholders’ equity to $56.93 million and book value per share to $3.06.

The company highlighted a signed letter of intent with the U.S. Department of Commerce CHIPS R&D Office for up to $30 million in potential funding, an expanded wafer-capacity agreement with Sumitomo Chemical Advanced Technologies, and a strategic shift from early-stage government R&D contracts toward AI datacom commercialization. Aeluma set November 19, 2026 as its next annual stockholder meeting date, with stockholder proposal and nomination notices due by September 26, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.04%
Tags
current report
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) director Steven Denbaars reported amended insider sales of common stock. He sold 12,500 shares on 2026-08-26 at a weighted average price of $13.8435 per share and another 12,500 shares on 2026-08-27 at a weighted average price of $13.8158 per share. Both transactions were effected under a Rule 10b5-1 trading plan adopted on November 20, 2025. The amendment states it was filed solely to include previously omitted details of this trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.30%
Tags
insider
Rhea-AI Summary

Aeluma, Inc. (ALMU) director Steven Denbaars reported two open-market sales of common stock. He sold 12,500 shares on August 26, 2026 at a weighted average price of $13.8435 per share and 12,500 shares on August 27, 2026 at a weighted average price of $13.8158, in multiple trades within the disclosed price ranges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.30%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) received a notice under Rule 144 that director Steven DenBaars plans to sell 25,000 shares of Aeluma common stock through broker Merrill Lynch. The shares were acquired on February 5, 2021 via an Incentive Stock Option exercised for cash and are being sold pursuant to a Rule 10b5-1 trading plan. The notice lists an approximate sale date of August 26, 2026 and reports 18,305,335 shares of common stock outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
other
-
Rhea-AI Summary

Aeluma, Inc. director and Chief Executive Officer Jonathan Klamkin reported several transactions in common stock on August 3, 2026. He recorded bona fide gifts totaling 40,000 shares, including a 20,000-share disposition of shares held indirectly through a family trust and a 20,000-share acquisition into direct ownership. He also sold 20,000 shares in open-market or private transactions under a Rule 10b5-1 trading plan adopted on December 3, 2025, consisting of 4,190 shares at a weighted-average price of $16.2918 per share (range $15.62–$16.61) and 15,810 shares at $16.8487 per share (range $16.62–$17.53).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.61%
Tags
insider
Rhea-AI Summary

Aeluma, Inc. entered a CHIPS and Science Act Letter of Intent with the U.S. Department of Commerce’s CHIPS Research & Development Office for up to $30 million in proposed funding. The LOI supports R&D and commercialization of Aeluma’s scalable non-InP photonics manufacturing platform for AI and advanced computing applications.

The potential award is subject to further due diligence, required U.S. government approvals, and execution of definitive award documents. The LOI contemplates a portion of funds paid up front and the balance on a milestone-based structure, with Aeluma issuing unregistered equity securities to Commerce with an aggregate value equal to any final award.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
current report

FAQ

How many Aeluma (ALMU) SEC filings are available on StockTitan?

StockTitan tracks 83 SEC filings for Aeluma (ALMU), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Aeluma (ALMU)?

The most recent SEC filing for Aeluma (ALMU) was filed on November 12, 2026.